Article Details
Retrieved on: 2019-03-05 22:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Venbio Select Advisor Llc increased its stake in Sarepta Therapeutics Inc (SRPT) by 35.14% based on its latest 2018Q4 regulatory filing with the SEC.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here